Ledger.Open graph →
SEC Form D · filed June 23, 2011

Ultragenyx Pharmaceutical Inc

Offering
$48.7M
Sold
$18.7M
Exemption
—
Industry
Biotechnology
Location
NOVATO, CA
Type
—

People & firms on this filing (9)

William Aliski · Novato, CADirectorThomas A. Lewis · Mesquite, TXDirectorMarten Steen · Lausanne, V8DirectorPharmacy Portfolio Iii, L.L.C · Oak Brook, ILDirectorEmil D. Kakkis · Novato, CAExec · DirectorPharmacy Portfolio III Exchange, L.L.C · Oak Brook, ILDirectorEran Nadav · San Francisco, CADirectorKenneth B. Mcelroy · SCOTTSDALE, AZExec · DirectorBen Auspitz · Cambridge, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗